AstraZeneca makes small front-end bet on potential asthma drug – Philly.com (blog)


Reuters

AstraZeneca makes small front-end bet on potential asthma drug
Philly.com (blog)
Having fended off Pfizer – for now, at least – AstraZeneca struck a much smaller deal to license a potential asthma drug being developed by Synairgen. AstraZeneca is based in the United Kingdom – London for now, but moving the headquarters to Cambridge …
AstraZeneca builds pipeline with $232 million Synairgen asthma dealReuters
AstraZeneca licenses IFN-beta therapy for viral-induced asthma exacerbationHealio
AstraZeneca extends global shopping spree with $232M asthma drug dealFierceBiotech
BioWorld Online
all 55 news articles »

View full post on asthma – Google News